Previous 10 | Next 10 |
DURECT Corporation to Announce Third Quarter 2022 Financial Results and Provide Business Update on November 2 PR Newswire CUPERTINO, Calif. , Oct. 26, 2022 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it will report its third...
DURECT Reaches Enrollment Milestone in Phase 2b AHFIRM Trial PR Newswire AHFIRM enrollment surpasses 200 of the planned 300 AH patients Enrollment completion now anticipated in Q2 2023 CUPERTINO, Calif. , Oct. 6, 2022 /PRNewswi...
Innocoll and DURECT Announce U.S. launch of POSIMIR® PR Newswire POSIMIR® is now commercially available in the U.S. for the treatment of post-surgical pain in adults following arthroscopic subacromial decompression surgery DURECT recently rece...
DURECT Corporation (DRRX) Q2 2022 Earnings Conference Call August 4, 2022, 4:30 PM ET Company Participants Tim Papp - Chief Financial Officer Jim Brown - Chief Executive Officer Norman Sussman - Chief Medical Officer Conference Call Participants Rick ...
Durect press release ( NASDAQ: DRRX ): Q2 GAAP EPS of -$0.05. Revenue of $2.08M (-9.6% Y/Y). At June 30, 2022, cash and investments were $54.3 million, compared to cash and investments of $70.0 million at December 31, 2021. Total debt at June 30, 2022 was $20.9 million...
DURECT Corporation Reports Second Quarter 2022 Financial Results and Update of Programs PR Newswire - Webcast of Earnings Call Today, August 4 th at 4:30 p.m. ET - Enrollment accelerating in the AHFIRM trial CUPERTINO, Calif. ,...
DURECT Corporation to Announce Second Quarter 2022 Financial Results and Provide Business Update on August 4 PR Newswire CUPERTINO, Calif. , July 27, 2022 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it will report its first ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors in penny stocks know that they are an inherently risky proposition. That goes double for any investor just getting into this market. But with great risk comes great reward. In this case, I think these are penny s...
Durect ( NASDAQ: DRRX ) appointed Timothy M. Papp as its CFO wherein he will direct and oversee all financial and capital markets activities. Mr. Papp has 25+ years of corporate finance experience, including 15 years in the Biopharma sector. ...
DURECT Corporation Appoints Timothy M. Papp as Chief Financial Officer PR Newswire CUPERTINO, Calif. , July 5, 2022 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company focused on epigenetic regulation to develop treatmen...
News, Short Squeeze, Breakout and More Instantly...
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis PR Newswire DURECT plans to confirm the efficacy and safety of larsucosterol in a registrational Phase 3 clinical trial CUPERTINO, Calif. , May ...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 171.6% to $0.1657 on volume of 180,907,472 shares AMC Entertainment Holdings Inc. Class A (AMC) rose 84.4% to $9.57 on volume of 174,658,682 shares Plug Power Inc. (PLUG) rose 45.9%...
DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update PR Newswire - FDA Feedback Supports Single Pivotal Trial for Approval of Larsucosterol in Alcohol-Associated Hepatitis - Webcast of Ea...